期刊文献+

VDCP方案联合甲磺酸伊马替尼治疗费城染色体阳性急性淋巴细胞白血病16例观察 被引量:3

下载PDF
导出
摘要 急性淋巴细胞白血病(ALL)诱导治疗的基本药物是长春新碱(VCR)和泼尼松(强的松)即VP方案,4周疗程的VDCP方案使成人ALL的缓解率提高至80%左右,但对费城染色体(Ph)阳性的ALL效果不佳。
出处 《中国乡村医药》 2010年第7期13-14,共2页
  • 相关文献

参考文献2

  • 1Gleissner B, Gokbuget N, Bartram CR, et al. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia:a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction arflysis[J]. Blood, 2002, 99:1536- 1543.
  • 2Talpaz M, Silver RT, Druker B J, et al. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia:results of a phase 2 study[J]. Blood, 2002, 99:1928-1937.

同被引文献50

  • 1游泳,李秋柏,王红祥,邹萍,陈智超.甲磺酸伊马替尼治疗复发或难治性Ph染色体阳性急性淋巴细胞性白血病的临床疗效分析[J].中华医学杂志,2004,84(17):1452-1453. 被引量:3
  • 2鲍立,江滨,黄晓军,王德炳,邱镜滢,卢锡京,陈欢,陆道培.Ph阳性急性淋巴细胞白血病的临床研究[J].中华血液学杂志,2005,26(1):31-34. 被引量:5
  • 3金正明,吴德沛,孙爱宁,仇惠英,唐晓文.伊马替尼治疗Ph阳性慢性髓细胞白血病急变期及急性淋巴细胞白血病39例[J].实用临床医药杂志,2005,9(8):53-54. 被引量:11
  • 4Yanada M, Nace T, Lida H, et al. Mydoablative allogeneic he- matopoietic stem cell transplantation for Philadelphia chromo- some-positive acute lymphoblastic leukemia in adults: signi- ficant roles of total body irradiation and chronic graft-versus- host disease[J]. Bone Marrow Transplant, 2005, 36(10): 867- 872.
  • 5Rowe JM, Buck G, Bumett AK, et al. Induction therapy for a- dults with acute lymphoblastic leukemia: results of more than 1 500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993[J]. Blood, 2005, 106(12): 3760-3767.
  • 6Wrzesiefi-Kus A, Robak T, Pluta A, et aL Outcome of treatme- nt in adults with Philadelphia chromosome-positive and/or B- CR-ABL-positive acute lymphoblastic leukemia- retrospec- tive analysis of Polish Adult Leukemia Group(PALG)[J]. Ann Hematol, 2006, 85(6): 366-373.
  • 7Ottmann OG, Wassmann B, Pfeifer H, et al. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic 1- eukemia(Ph^+ ALL)[J]. Cancer, 2007, 109(10): 2068-2076.
  • 8Yanada M, Takeuchi J, Sugiura I, et al. High complete remissi- on rate and promising outcome by combination of Imatinih and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase Ⅲ study by the lapan Aduh Leukemia Study Group [J]. J Clin Oncol, 2006, 24(3): 460- 466.
  • 9Thomas DA, Faded S, Cortes J, et ol. Treatment of Philadelph- ia chromosome-positive acute lymphocytic leukemia with hyp- er-CVAD and Imatinib mesylate [J]. Blood, 2004, 103 (12): 4396-4407.
  • 10Carpenter PA, Snyder DS, Flowers ME, et al. Prophylactic ad- ministration of Imatinib after hematopoietic cell transplanta- tion for high-risk Philadelphia chromosome-positive leukemia [J]. Blood, 2007, 109(7): 2791-2793.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部